Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)-Reference-Cited by-同舟云学术

Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)

Published:2015-01-17 Issue:1 Volume:10 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Ghadjar Pirus, ,Hayoz Stefanie,Zimmermann Frank,Bodis Stephan,Kaul David,Badakhshi Harun,Bernier Jacques,Studer Gabriela,Plasswilm Ludwig,Budach Volker,Aebersold Daniel M

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-014-0319-y.pdf

Reference8 articles.

1. Ghadjar P, Simcock M, Studer G, Allal AS, Ozsahin M, Swiss Group for Clinical Cancer Research (SAKK), et al. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). Int J Radiat Oncol Biol Phys. 2012;82:524–31.

2. Van Den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Tan IB, et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer. 2004;101:1809–17.

3. Langius JAE, Bakker S, Rietveld DHF, Kruizenga HM, Langendijk JA, Weijs PJ, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Brit J Cancer. 2013;109:1093–9.

4. Pai PC, Chuang CC, Tseng CK, Tsang NM, Chang KP, Yen TC, et al. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. Int J Radiat Oncol Biol Phys. 2012;83:e93–100.

5. Cho YW, Roh JL, Jung JH, Kim SB, Lee SW, Choi SH, et al. Prediction of posttreament significant body weight loss and its correlation with disease-free survival in patients with oral squamous cell carcinomas. Nutr Cancer. 2013;65:417–23.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Percutaneous Endoscopic Gastrostomy for the Nutrition of Head and Neck Cancer Patients before and up to 6 Months after Cancer Treatment;Cancers;2024-09-12

2. Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy;Nutrition and Cancer;2024-05-17

3. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies;ESMO Open;2024-03

4. Head and neck carcinoma in patients not eligible for platinum;Revisiones en Cáncer;2024

5. Prognostic significance of MRI-defined sarcopenia in patients with nasopharyngeal carcinoma: A propensity score matched analysis of real-world data;Radiotherapy and Oncology;2023-11